Oxybutynin Hydrochloride en es it fr

Oxybutynin Hydrochloride Brand names, Oxybutynin Hydrochloride Analogs

Oxybutynin Hydrochloride Brand Names Mixture

  • No information avaliable

Oxybutynin Hydrochloride Chemical_Formula

C22H31NO3

Oxybutynin Hydrochloride RX_link

http://www.rxlist.com/cgi/generic/ditropan.htm

Oxybutynin Hydrochloride fda sheet

Oxybutynin_Hydrochloride FDA

Oxybutynin Hydrochloride msds (material safety sheet)

Oxybutynin_Hydrochloride MSDS

Oxybutynin Hydrochloride Synthesis Reference

Brit. pat. 940540 (1963 to Mead Johnson)

Oxybutynin Hydrochloride Molecular Weight

357.486 g/mol

Oxybutynin Hydrochloride Melting Point

129-130 oC

Oxybutynin Hydrochloride H2O Solubility

No information avaliable

Oxybutynin Hydrochloride State

Solid

Oxybutynin Hydrochloride LogP

4.683

Oxybutynin Hydrochloride Dosage Forms

Patch; Syrup; Tablet; Tablet (extended-release)

Oxybutynin Hydrochloride Indication

For the treatment of overactive bladder.

Oxybutynin Hydrochloride Pharmacology

Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer.

Oxybutynin Hydrochloride Absorption

Rapidly absorbed from gastrointestinal tract.

Oxybutynin Hydrochloride side effects and Toxicity

LD50=1220 mg/kg (Orally in rats, Goldenthal)

Oxybutynin Hydrochloride Patient Information

PATIENT INFORMATION
Patient should be informed that oxybutynin may produce drowsiness or blurred vision. Alcohal may enhance the drowsiness caused by anticholinergic agents. Fever and heat stroke can occur while anticholinergics are administered in the presence of high environmental temparature. Medication should be taken with the aid of liquids at approximately the same time each day. Patients should not chew, divide, or crush tablets.

Oxybutynin Hydrochloride Organisms Affected

Humans and other mammals